10-Q: Lifeway Foods Reports Strong Q3 Growth, Boosted by Kefir Sales

Lifeway Foods, Inc. announced robust financial results for the third quarter and first nine months of 2025, driven by increased kefir volumes and improved gross profit margins.

Summary

• Net sales for the three months ended September 30, 2025, increased by 24.0% to $57.1 million, compared to $46.1 million in the prior year.
• On a comparable basis, adjusting for an exited customer relationship and a distributor shift, net sales increased approximately 29% in Q3 2025.
• Gross profit margin improved to 28.7% for Q3 2025, up from 25.7% in Q3 2024, primarily due to higher branded product volumes and favorable conventional milk pricing.
• Net income for Q3 2025 rose by 18.6% to $3.5 million, or $0.23 per diluted share, compared to $3.0 million, or $0.19 per diluted share, in Q3 2024.
• For the nine months ended September 30, 2025, net sales grew by 12.3% to $157.1 million, with comparable net sales increasing approximately 19%.
• Nine-month net income increased by 23.2% to $11.3 million, or $0.74 per diluted share, compared to $9.2 million, or $0.60 per diluted share, in the prior year.
• The company recognized a $3.4 million gain from the sale of its equity investment in Simple Mills during the nine-month period.
• General and administrative expenses increased significantly due to approximately $2.4 million in professional fees related to the Danone unsolicited purchase proposal and non-routine stockholder action in Q3 2025, totaling $4.3 million for the nine months.
• Lifeway is expanding its Waukesha, Wisconsin facility with an estimated $45 million investment to double manufacturing capacity and improve packaging efficiency, expected to be completed in Q4 2026.
• The company initiated an organic milk supply program by purchasing 402 mature dairy cows for $1.3 million in Q3 2025, entering a 60-month Herd Agreement with a third-party dairy.
• The revolving credit facility was increased from $5 million to $25 million and extended to February 5, 2028, with $25 million available for future borrowings as of September 30, 2025.
• The Shareholder Rights Agreement was extended to October 29, 2026.

Sentiment

Score: 8

Explanation: The company demonstrated strong revenue growth, improved gross margins, and increased net income, supported by strategic investments and a significant gain from an investment sale. While G&A expenses rose due to specific non-recurring events, the underlying operational performance and future growth initiatives are positive. The strong liquidity position further enhances confidence.

Positives

• Net sales increased by 24.0% for the three months and 12.3% for the nine months ended September 30, 2025, demonstrating strong top-line growth.
• Comparable net sales growth was even stronger, at approximately 29% for Q3 and 19% for the nine months, after adjusting for specific customer dynamics.
• Gross profit margin improved to 28.7% in Q3 2025 (from 25.7%) and 27.3% for the nine months (from 26.2%), driven by higher volumes and favorable conventional milk pricing.
• Net income saw significant increases of 18.6% for Q3 and 23.2% for the nine months, reflecting improved profitability.
• A $3.4 million gain was realized from the sale of the Simple Mills investment, contributing positively to net income.
• The company's liquidity position is strong, with cash and cash equivalents increasing to $22.99 million and $25 million available under the expanded revolving credit facility.
• Strategic investments in manufacturing capacity expansion at the Waukesha facility are underway to meet increasing sales demand and improve efficiency.
• The new organic milk supply initiative aims to secure a more stable and increased supply of organic milk, supporting future growth.

Negatives

• General and administrative expenses increased substantially by 73.6% in Q3 2025 and 31.1% for the nine months, primarily due to $2.4 million (Q3) and $4.3 million (9 months) in professional fees related to the Danone unsolicited purchase proposal and non-routine stockholder action.
• Selling expenses increased by 26.8% in Q3 and 28.5% for the nine months, outpacing net sales growth, due to continued investments in marketing activities.
• Income from operations for the nine months ended September 30, 2025, decreased by 5.6% to $12.4 million, compared to $13.1 million in the prior year, largely impacted by the increased G&A expenses.

Risks

• Changes in the pricing of commodities, particularly milk, could impact cost of goods sold and gross margins.
• Actions and decisions of competitors and customers, including those related to price competition, may affect market share and profitability.
• The company's ability to successfully implement its business strategy, including growth initiatives and facility expansions, is crucial for future performance.
• Effects of government regulation could impose additional costs or restrictions on operations.
• Disruptions to the supply chain, or manufacturing and distribution capabilities, including those due to cybersecurity threats, could impact production and delivery.
• Adverse economic conditions in the United States, the primary market, or other jurisdictions, and resultant changes in consumer spending, could negatively affect demand for products.
• The company relies on two significant customers for a substantial portion of its net sales (24% for the nine months ended September 30, 2025), posing customer concentration risk.

Future Outlook

The company anticipates maintaining compliance with its loan agreements and possessing sufficient liquidity to fund ongoing business operations, capital requirements, and growth initiatives. Management expects the accelerating consumer focus on health and wellness to drive increased demand for its products. Macroeconomic conditions, including inflation and tariffs, are not currently expected to have a material adverse impact on operations or financial results. The Waukesha facility expansion is projected to be completed during the fourth fiscal quarter of 2026.

Management Comments

• We continue to monitor macroeconomic conditions and global trade developments, including inflation in key input costs, recently implemented tariffs, and the potential for additional or modified tariffs or export controls.
• We expect the accelerating consumer focus on health and wellness to drive increased demand for our products.
• The Waukesha facility expansion project will be funded primarily through cash on-hand and cash flow from operations, with further requirements available under the company's revolving credit facility.

Industry Context

Lifeway Foods operates in the growing health and wellness segment of the food and beverage industry, specifically within cultured dairy products. The company's focus on kefir aligns with broader consumer trends favoring probiotic-rich foods and 'better-for-you' options. Its strategic investments in manufacturing capacity and securing organic milk supply position it to capitalize on this increasing demand, while its primary market in the U.S. remains robust for such products. The company's growth outpaces general dairy industry trends, indicating strong product acceptance and market penetration within its niche.

Comparison to Industry Standards

• NA

Corporate Governance

Legal Proceedings

• The company is involved in various legal proceedings, claims, disputes, regulatory matters, audits, and proceedings arising in the ordinary course of business. Management believes that current accruals for outstanding legal matters are not material individually or in the aggregate, and the ultimate resolution is not expected to have a material adverse effect on the business, financial condition, results of operations, or cash flows.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, increased EPS, and strategic growth initiatives. The extension of the Shareholder Rights Agreement aims to protect their interests.
• Employees: Potential positive impact from facility expansion and continued growth, possibly leading to job creation or stability.
• Customers: Benefit from increased product availability and potentially improved quality/efficiency due to manufacturing investments.
• Suppliers: The organic milk supply initiative creates a new, structured relationship with a COOP and a third-party Dairy, ensuring a stable supply chain.
• Creditors: The company's strong liquidity and compliance with debt covenants, along with an expanded credit facility, indicate a healthy financial position, reducing credit risk.

Next Steps

• Continue monitoring macroeconomic conditions, including inflation and tariffs.
• Complete the Waukesha, Wisconsin facility expansion project, expected by Q4 2026.
• Manage the Herd Agreement for organic milk supply, with monthly payments from the Dairy commencing December 1, 2025.
• Continue investments in marketing activities to drive brand awareness and sales volumes.
• Adoption of new accounting standards: ASU 2023-09 (Income Taxes) effective for fiscal year ending December 31, 2025, and ASU 2024-03 (Income Statement Expense Disaggregation Disclosures) effective for annual period ending December 31, 2027.

Key Dates

Recommendation

Lifeway Foods demonstrates strong operational momentum with significant top-line growth, improved gross margins, and a healthy increase in net income. The strategic investments in manufacturing capacity and organic milk supply are forward-looking moves that position the company for sustained growth in the expanding health and wellness market. While professional fees related to the Danone proposal impacted G&A, this appears to be a non-recurring item. The company's strong liquidity and expanded credit facility provide ample financial flexibility. The overall performance and strategic direction suggest a positive outlook, making it an attractive investment.

Keywords

Kefir, Cultured Dairy, Probiotic, Organic Milk, Dairy Products, Financial Results, SEC Filing, LWAY, Food & Beverage, Consumer Staples, Manufacturing Expansion, Shareholder Rights Plan